A Phase 4 Study of Regorafenib in Metastatic Colorectal Cancer - Does Educating Physicians Change Patient Outcomes?

Dose(s) 160 mg tablet (4 tablets per day at 40 mg) daily for 3 weeks on / 1 week off

Investigators were supported with enhanced drug-specific information via an iPad application (SMART).

The treating investigator will have access to the prescribing information and have ability to consult a Bayer specialist, should questions arise.